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The thesis entitled “Metathesis based approaches for the synthesis of aminocyclitol 
moieties of trehazolin and trehalostatin, isoaspinonene, leiocarpin C and (+) goniodiol” 
is divided into three chapters. 
 
Chapter I: Stereoselective total synthesis of aminocyclitol moieties of trehazolin and 
trehalostatin via enyne metathesis protocol 
 
This chapter deals with the stereoselective synthesis of aminocyclitol moieties of 
trehazolin and trehalostatin via enyne metathesis protocol 
 
 Trehalose is the characteristic blood sugar and reserve carbohydrate of many insects 
and trehalase plays an important role in the metabolism of trehalose in insects and fungi.
1
 In 
this way specific inhibitors of trehalase may find applications in the regulating the trehalose 
metabolism and thus pave way for the discovery of new insecticides. A diverse collection of 
naturally occurring trehalase inhibitors is known, most often many of which contain an 
aminocyclopentitol unit. Trehazolin and trehalostatin (Figure1) come under this collection. 
Therefore, it is not surprising that their total synthesis
2 
and the elucidation of SARs
3
 have 
received much interest. Trehazolin, isolated by Ando and coworkers from the culture broth of 
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-spora strain SANK 62390, has been shown to be powerful inhibitor of trehalase in vitro 
(IC50 0.016 µg/mL for silkworm trehalase).
4 
Aminocyclopentitol moiety 1a of trehazolin is 
known as trehazolamine. Trehalostatin was isolated by Murao et al. from the culture broth of 
Amycolatopsis trehalostatica.
5
 Interestingly, both the aminocyclopentitols of trehazolin 
(trehazolamine 1a) and trehalostatin (epi-trehazolamine 2a) share C-2 epimeric relationship 
with each other. Structurally, both 1a and 2a are densely functionalized with contiguous 
chiral groups; while the C1 carbon bears a chiral tertiary hydroxy group and a hydroxy 
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methyl group, the C2, C3 and C4 carbon atoms are endowed with the hydroxy groups and the 
C5 is decorated with an amino functionality. Due to the above cited reasons, these two 
aminocyclopentitols are attractive synthetic targets.
2 
Herein this chapter the synthesis of both 
trehazolamine and epi-trehazolamine as their derivatives by enyne metathesis protocol is 
described. 
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 Enyne metathesis
6,7
 has emerged as a powerful tool for the construction of carbocylic 
ring systems. In continuation of the interest on the total synthesis of bioactive aminocyclitols 
containing natural products,
7 
the total synthesis of trehazolamine and epi-trehazolamine as 
their hexaacetates is described. The retrosynthetic analysis of our approach is shown in 
Scheme 1. Thus the targets 1b and 2b could be readily assembled by elaboration of precursor 
3 using Sharpless asymmetric epoxidation followed by the regioselective epoxide ring-
opening reaction with sodium acetate followed by acetylation. The later could be obtained by 
the substrate directed dihydroxylation reaction and acetylation. Allylic alcohol 3 in turn was 
envisioned from 1-vinyl cyclopentene 4 wherein it was presumed that the vinylic double 
bond would serve as the masked ‘hydroxymethyl side chain’ that could be generated by a 
sequential regioselective dihydroxylation-oxidative cleavage-reduction reaction set. While 
diene 4 was accessed from the enyne 5 via the crucial enyne metathesis reaction and the 
enyne system 5 was realized from Garner’s aldehyde 6.  
 
Results and discussion  
 Thus, the known precursor7 7 (Scheme 2) on Swern oxidation (DMSO/(COCl)2/CH2Cl2/Et3N/-
78 
o
C/1 h) and Wittig olefination (Ph3P
+
CH3I
-
/KO
t
Bu/THF/0 
o
C to rt/3 h) furnished olefin 8 
(65%). Next the olefin 8 on acetonide deprotection (CuCl2.2H2O/CH3CN/0 
o
C/10 min) 
afforded primary alcohol 9 (95%). Alcohol 9 was oxidized to aldehyde under Swern 
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conditions and the aldehyde thus obtained was converted into vinyl dibromide 
(CBr4/TPP/Et3N/CH2Cl2/-10 
o
C/2 h) which under Grignard conditions (EtMgBr/THF/0 
o
C/10 
min) was transformed into a acetylenic compound enyne 5 (88% over three steps). Enyne 5 
underwent a facile metathesis reaction {G-II (IA, 10 mol%)/toluene/110 
o
C/10 h} to afford 
the 1-vinylcyclopentene system 4 (91%). Compound 4 was identified from its spectral data. 
The 
1
H NMR spectrum of 4 indicated the absence of acetylenic proton whilst displaying the  
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Reagents and conditions: (a) Ref. 7; (b) i) DMSO, (COCl)2, CH2Cl2, Et3N, -78
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+CH3I
-, 
KOtBu, THF, -10 oC to rt, 3 h, 65% (over two steps); (c) CuCl2.2H2O, CH3CN, 0
oC, 10 min, 95%; (d) i)
DMSO, (COCl)2, CH2Cl2, Et3N, -78
oC, 1 h; ii) CBr4, TPP, Et3N, CH2Cl2, 0
oC, 2 h; iii) EtMgBr, THF, 0
oC, 10 min, 88% (over three steps); (e) G-II (IA, 10 mol%), toulene, 110 oC, 10 h, 91%; (f) i) OsO4, NMO, 
acetone: H2O (4:1), rt, 2 h; ii) NaIO4, MeOH: H2O (9:1), 5 min, rt; iii) NaBH4, MeOH, 0
oC, 5 min, 73%
(over three steps); (g) (-)-DIPT, Ti(OiPr)4, TBHP, CH2Cl2, -20
oC, 24 h, 60%; (h) i) NaOAc, H2O: DMF
(1:1), 120 oC, 24 h; ii) TFA, CH2Cl2, 0
oC, 8 h; iii) Ac2O, Py, DMAP, 24 h, rt, 70% (over three steps); (i)
OsO4, NMO, acetone : H2O (4:1), 4 h, 80%; (j) i) TFA, CH2Cl2,  0
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characteristic olefinic protons at δ 6.30 ppm as a double doublet (J = 17.5, 11.7 Hz), at δ 5.76 
ppm as a singlet, at δ 5.49 ppm as a doublet (J = 17.5 Hz) and at δ 5.22 ppm as a doublet (J = 
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10.9 Hz). The HRMS spectrum displayed the [M+Na]
+
 352.1727, calculated 352.1736 for the 
molecular formula C16H27NO6Na. 
 According to the envisaged plan, the next task was to differentiate between the two 
olefins and functionalize selectively the vinylic olefin into the hydroxymethyl side chain. 
Hence, a sequential dihydroxylation-oxidative cleavage-reduction protocol was invoked. 
Thus, the terminal olefinic bond of the conjugated diene 4 on regioselective dihydroxylation 
{OsO4/NMO/acetone:H2O (4:1)/rt/2 h} furnished the corresponding diol which on oxidative 
cleavage (NaIO4/MeOH/H2O/rt/5 min) and reduction of the in situ generated aldehyde 
(NaBH4/MeOH/rt/5 min) gave the crucial allylic alcohol 3 (73% over three steps). Allylic 
alcohol 3 underwent Sharpless epoxidation
8 
{(-)-DIPT/Ti(O
i
Pr)4/TBHP/-20 
o
C/24 h} to give 
chiral epoxide 10 (60%) which on ring-opening reaction with the acetate ion 
{NaOAc/DMF:H2O(1:1)/120 
o
C/24 h}, one-pot deprotection (TFA/CH2Cl2/0 
o
C/8 h) of 
MOM and Boc groups followed by acetylation (Ac2O/Py/DMAP/rt/24 h) afforded  
compound 1b (70%). Compound 1b was identical in all respects with the hexaacetate of 
trehazolamine ([α]
25
D +5.9 (c 0.4, CHCl3).
2 h,j
  
 Likewise allylic alcohol 3 on dihydroxylation
9
 (OsO4/NMO/acetone: H2O/rt/4 h) gave 
the corresponding triol 11 (80%) as the major diastereomer (8:2). The requisite major isomer 
on global deprotection (TFA/CH2Cl2/0 
o
C/8 h) followed by acetylation 
(Ac2O/Py/DMAP/rt/24 h) afforded hexaacetate of epi-trehazolamine 2b (75%), {[α]
25
D -8.5 (c 
0.4, CHCl3)}.
 
The HRMS spectrum displayed the [M+Na]
+
 454.1338, calculated 454.1325 
for the molecular formula C18H25NO11Na. 
 In summary, the stereoselective total synthesis of trehazolamine and epi-trehazolamine 
as their hexaacetates 1b and 2b respectively using enyne metathesis as the key step is 
described herein this chapter. The strategy described could be adopted for the synthesis of 
similar targets. 
 
Chapter 2: The first stereoselective total synthesis of isoaspinonene via Baylis-Hillman 
reaction and olefin cross-metathesis protocol 
 
This chapter deals with the first stereoselective total synthesis of isoaspinonene via 
Baylis-Hillman reaction and olefin cross-metathesis protocol 
 
                                                                                                                                        Synopsis 
 
5 
 
 Isoaspinonene (12) was
 
produced from the cultures of Aspergillus ochraceus.
10
 The 
other aspinonene/aspyrone co-metabolites are trienediol, aspinolide A, B, C, dihydroaspyrone 
and dienetriol (Figure 2). All the structures were determined by detailed spectroscopic 
analysis. Secondary metabolites are useful for transferring their chirality to the desired 
products.  
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 The tetrahydrofuran 12 considered to be biosynthesized from an intramolecular 
nucleophilic attack of the primary hydroxyl group on epoxide in co-metabolite 13 (Scheme 
3). 
OH
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Scheme 3. Proposed biogenetic relationship between 12 and 13  
  
 Tetrahydrofurans are the core unit of many natural products.
11
 Construction of optically 
pure 2,3,4-trisubstituted tetrahydrofuran has remained an attractive target because of its 
ubiquitous presence as the core structure of furano lignan class of natural products.
12
 It was 
noticed that natural products belonging to this class exhibit ‘2,3-trans and 3,4-trans’ 
stereochemistry (e.g., sesaminone, magnolone).
13
  
 Baylis-Hillman reaction is a well known protocol for the preparation of multifunctional 
products with a newly created chiral center, predominantly is an anti-isomer when the 
electrophile is a chiral entity. These adducts constitute versatile synthetic intermediates in 
synthesis of natural products. Over the last few years, our group was involved in expanding 
the horizon of Baylis-Hillman reaction
14a
 and found varied applications of the corresponding 
adducts.
14b–d
 Herein intermediate 24 (Scheme 4) that could be realized from Baylis-Hillman 
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reaction was identified as an important precursor in the synthesis, which could be used for the 
synthesis of 2,3,4-trisubstituted tetrahydrofuran 23 which in turn could be used for the total 
synthesis of isoaspinonene. Baylis-Hillman reaction and tetrahydrofuran ring formation is 
useful for the synthesis of different 2,3,4-trisubstituted tetrahydrofurans which inturn also 
useful for the synthesis of other isomers of isoaspinonene. 
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 As a part of our interest in the stereoselective synthesis of biologically active natural 
products based on olefin cross-metathesis,
15
 a simple and concise route to 12 was devised. 
Earlier, one of the members from this family, i.e. aspinolide B was synthesized in our 
group.
16
 In continuation, herein, a convergent approach toward the first total synthesis of 12 
starting from inexpensive and commercially available starting materials; propylene oxide, D-
glucose and (S)-ethyl lactate is described.  
 Our synthetic route relies on strategically novel synthetic protocol involving reactions 
like Baylis-Hillman reaction, Grignard reaction, Wittig olefination, and olefin cross-
metathesis. Accordingly, our envisaged retrosynthetic analysis for 12 is based on convergent 
approach as shown in Scheme 4. trans-Olefinic double bond of 12 could be constructed by 
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the cross-metathesis of olefin 18 with allylic alcohol 19a. Compound 19a could be obtained 
by vinylation of ketone 20a. For accessing cyclic ketone 20a, two synthetic routes namely 
‘asymmetric approach’ (Path A) and ‘chiron approach’ (Path B) are described. Path A could 
be realized through the MOM-protected cyclic ether 23 which could be obtained from rac-
propylene oxide using Baylis-Hillman reaction as the key step or by path B from alcohol 21 
starting from D-glucose. Alcohol 21 could be obtained from diol 22 and it in turn could be 
derived from D-glucose. Alternatively, cyclic ether 23 could be prepared from Baylis-
Hillman adduct 24, which could be realised from chiral aldehyde 25 that could be easily 
generated from propylene oxide. Olefin 18 could be realized from (S)-ethyl lactate by 
TBDPS-etherification, reduction of ester functionality to aldehyde and followed by Wittig 
olefination. 
 
Results and discussion 
 As shown in Scheme 5, Baylis-Hillman reaction of aldehyde 25
16
 which could be 
generated from propylene oxide via hydrolytic kinetic resolution, with ethyl acrylate to give 
adduct 26 (85%) as a mixture of diastereomers (in 9.4:0.6 ratio as determined by HPLC). 
Secondary hydroxyl group in the adduct 26 was protected using MOM-Cl as its methoxy 
methyl ether 24 (90%). 
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Reagents and conditons: (a) ethyl acrylate, DABCO, DMSO, rt, 24 h, 85%; (b) MOM-Cl, DIPEA,
CH2Cl2, 0 
oC to rt, 24 h, 90%; (c) i) DDQ, CH2Cl2:H2O (9:1), 0 
oC to rt, 1 h, 95%; ii) DIBAL-H, CH2Cl2, 
0 oC to rt, 0.5 h, 93%; (d) TsCl, Et3N, CH2Cl2, 0 
oC to rt, 24 h, 81%; (e) O3, CH2Cl2, -78 
oC, 1 h, 95%.
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 PMB group in 24 was deprotected by treating with DDQ, and the ester group was 
reduced to alcohol by DIBAL-H to produce diol 27 (88% over two steps). The diol 27 was 
treated with TsCl for selective tosylation at primary position. Thus, resulted tosyl product on 
internal nucleophilic substitution by secondary hydroxyl group with concomitant elimination 
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of the tosyl group led to cyclic ether 23 (81%). Ozonolysis of cyclic ether 23 produced ketone 
28 and MOM deprotected ketone 29 (95% combined yield). 
O
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Reagents and conditions: (a) i) TFA, CH2Cl2, 0 
oC to rt, 1 h; ii) AcCl, Et3N, 
CH2Cl2, 0 
oC to rt, 1 h, 90% (over two steps); (b) O3, CH2Cl2, rt, 1 h, 90%.
a
Scheme 6
 
  
 Under these ozonolysis conditions, it was observed that MOM protecting group was 
deprotected to result in 29 (15%). Hence, as in Scheme 6, alternate route was contemplated. 
MOM was deprotected prior to ozonolysis using TFA and the hydroxyl group was 
reprotected as its acetyl ester 30 (90% over two steps) with AcCl which upon ozonolysis 
afforded the acetylated ketone 20a in 90% yield. An acetyl group was considered as the 
appropriate protecting group because it can survive the ozonolysis conditions.  
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Reagents and conditions: (a) Ref. 17 (b) i) 40% aq. AcOH, H2SO4, reflux, 1 h; ii) NaIO4,
MeOH:H2O (9:1), rt, 0.5 h; iii) NaBH4, MeOH, 0
oC to rt, 10 min (88% over three steps);
(c) i) TsCl, Et3N, CH2Cl2, 0
oC to rt, 24 h; ii) K2CO3, MeOH, rt, 0.5 h, 81% (over two
steps); (d) i) AcCl, Et3N, CH2Cl2, 0 
oC to rt, 0.5 h, 85%; ii) Pd-C, H2, EtOAc, rt, 3 h, 90%; 
(e) DMP, CH2Cl2,  0 
oC to rt, 1 h, 92%.
Scheme 7
 
 
  Chiron approach for the synthesis of 20a is shown in Scheme 7. Thus the the 
acetonide group of benzoate ester 31
17
 was hydrolyzed with 40% aq. acetic acid under reflux 
conditions to furnish the corresponding diol, which on oxidative cleavage using NaIO4 and 
reduction of the in situ generated aldehyde with NaBH4 gave the crucial diol 22 (88% over 
three steps). The diol 22 on selective tosylation by treating with TsCl resulted in tosylated 
product, which on intramolecular nucleophilic attack with oxyanion generated using K2CO3 
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produced cyclic ether 32 (81% over two steps). Secondary alcohol of ether 32 was protected 
with AcCl as acetyl ester (85% yield) and benzyl group of resulted acetyl ester was 
deprotected under hydrogenation conditions resulted secondary alcohol 21 (90%). Alcohol 21 
underwent oxidation by Dess-Martin Periodinane (DMP) resulted in ketone 20a (92%).  
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(a) NaBH4, MeOH, 0 
oC, 15 min, 95%; (b) vinylMgBr, THF, -78 oC, 1 h, 93 and 
90%; (c)  K2CO3, MeOH, rt, 0.5 h,, 90%; (d) TFA, CH2Cl2, 0 
oC to rt, 1 h, 85%.
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 The ketone 20a underwent vinylation (Scheme 8) with vinylMgBr to yield crucial 
tertiary allylic alcohol 19a (93%) in a diastereomeric ratio of 9:1 (as determined by 
1
H NMR 
spectral analysis) in favor of the required isomer. Herein, unlike the conventional cyclic 
alkoxy ketones,
18 
the present substrate 20a is endowed with more nucleophilic ring oxygen 
which participates in the five-membered chelation complex involving ketone functional 
group with magnesium to facilitate the anti-addition
 
to
 
result in compound 19a in high 
selectivity. 
no. ketone reagent yield (%)
diastereomeric
        ratio
1 20a vinyl MgBr
vinyl MgBr
NaBH420a
28
2
3
93
95
90
 9:1a
9.1:0.9b
9.5:0.5a
Table 1. Examples for stereoselective additions to ketones
solvent
THF
THF
MeOH
T(oC)/t (h)
-78/1
0/0.25
-78/1
a
 Determined by 1HNMR.
b  Determined by HPLC.
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In order to validate the hypothesis that ring-oxygen atom is involved in the 
complexation during the addition reaction and dictates the stereochemical outcome and not 
the oxygen of 3-acetoxy/3-hydroxy group/3-MOM-ether, we conducted additional 
experiments and the results are listed in Table 1. For instance, when 20a was subjected to the 
hydride addition (wherein the counter cation is Na
+
) the addition occurred as earlier to afford 
20b (entry 2, Table 1). Next, 28 was selected as the test substrate, wherein the vinyl addition 
reaction proceeded as in the previous case (20a) to afford 28a in high selectivity. 
Subsequently in order to prove that the addition reaction favored anti-products, 19a and 28a 
were subjected to respective deprotection reactions to afford the respective diols (19b) which 
were then compared. It was found that the diols obtained from 19a and 28a shared 
comparable data. This chemical correlation method proves the anti-addition of two variable 
substrates. Interestingly 20b was identified as the starting material 21 and bear the identical 
data. Thus these set of reactions established the fact that the ring-oxygen plays the crucial 
role and not otherwise nor the counter cation has any role in the addition reaction. It also 
proves the relative anti-stereochemistry of C3 and C4 carbons of the addition products 
unequivocally. 
 
Thus the absolute stereochemistry at C4 was assigned as ‘R’ from the above 
experiments. Allylic alcohol 19a constitutes an important fragment of the cross-metathesis 
reaction. 
COOEt
OH
COOEt
OTBDPS OTBDPS
18
a b
Reagents and conditions: (a) TBDPSCl, imidazole, CH2Cl2, 0 
oC to rt, 3 
h, 96%; (b) i) DIBAL-H, CH2Cl2, -78
oC, 1 h; ii) Ph3P
+CH3I
-, KOtBu,
THF, -10 oC to rt, 6 h, 61% (over two steps).
Scheme 9
 
  
 Next the synthesis of other olefinic partner 18 (Scheme 9) was planned. Thus, TBDPS 
protected (S)-ethyl lactate is underwent reduction with DIBAL-H at -78 
o
C to give aldehyde, 
which on Wittig olefination gave olefin 18 (61% over two steps). 
 In order to construct the main skeleton of the target 12, coupling of the two olefinic 
partners 18 and 19a using olefin cross-metathesis protocol was used. Initially, the reaction in 
CH2Cl2 and toluene as the solvents was attempted. However, the best result was obtained 
when olefin cross-metathesis was performed using 18 and 19a in 2:1 ratio, in toluene and at 
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110 
o
C (Table 2, entry 4). All the results are presented in Table 2. As outlined in Scheme 10, 
the crucial olefin cross-metathesis reaction using Hoveyda-Grubbs II
19
 catalyst (IIA, 10 
mol%/toluene) in between 18 and 19a (2:1 ratio) resulted in the cross product 33 (60%) as a 
single stereoisomer with E-configuration (as characterized by 
1
H NMR) in which the olefinic 
protons resonated at δ 5.82 ppm, J = 15.2 Hz and at δ 5.47 ppm, J = 15.6 Hz indicating the 
trans geometry of olefinic protons and a small amount of homo-dimer 34 (5%).  
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Reagents and conditions: (a) Hoveyda-Grubbs-II (IIA) 10 mol%, toluene, 110 oC, 1 h, 60%.
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Table 2. Study of the olefin cross-metathesis reaction of 18 and 19a 
under various conditions.
Entry 18 : 19a
(equiv)
Catalyst
(10 mol%)
Solvent Time Yield
a %
33 : 34
1
3
4
1:2
2:1
2:1
IIA
IIA
IIA
CH2Cl2
20 h
Toluene 1 h
20 h
60 : 5
60 : 5
60 : 10
Temp oC
40
40
110
2 1:2 IIA Toluene 1 h 60 : 10110
CH2Cl2
a Isolated yields after purification by column chromatography.  
    
 Now, all that remained to complete the synthesis was to hydrolyze acetyl ester and 
deprotect the TBDPS group (Scheme 11). Thus, the cross-product 33 has hydrolyzed in 
presence of K2CO3 to produce 35 (94%) followed by the deprotection of silyl ether with 
TBAF to furnish the target 12 (80%). 
                                                                                                                                        Synopsis 
 
12 
 
O
OH
OH
OTBDPS
b
12
a
35
Reagents and conditions: (a) K2CO3, MeOH, rt, 0.5 h, 94%; (b) TBAF, CH2Cl2, 0
 oC to rt, 12 h, 80%.
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 In summary, this chapter describes the first stereoselective synthesis of isoaspinonene 
(12) was achieved by Baylis-Hillman reaction and cross-metathesis strategy which was used 
to access the advanced intermediate (33) that was endowed with all stereogenic centers and 
was easily transformed to the target compound 12. 
 
Chapter III: Total synthesis of leiocarpin C and (+)-goniodiol via olefin cross-metathesis 
protocol 
 
 This chapter deals with the total synthesis of leiocarpin C and (+)-goniodiol via olefin 
cross-metathesis protocol 
 
 Leiocarpin C (37) is a natural styryl lactone. Styryl lactones are natural products 
exhibiting significant biological activities like antitumor, antifungal and antibiotic 
properties.
20
 Lactone 37 (Figure 3) was isolated from the stem bark of tropical plant 
Goniothalamus leiocarpus.
21
 Recently two syntheses of 37 were reported.
22
 (+)-Goniodiol 
(36) was isolated from the stem bark of Goniothalamus gigantus and from the leaves and 
twigs of Goniothalamus sesquipedalis.
23b
 36 is selectively cytotoxic against human lung 
carcinoma cells A-549 (ED50 = 0.12 µg/mL
-1
) and p-388 murine leukemia cells (IC50 = 4.56 
µg/mL
-1
).
23
 It is pertinent to mention that there are many syntheses of 36 are reported.
22,24
  
Impressed with the bio-profile coupled with the group’s interest in the synthesis of such 
pyrone containing natural products,
25
 total synthesis of 36 and 37 was undertaken. Herein the 
total synthesis of 37 and 36 by strategically novel synthetic methodology involving olefin 
cross-metathesis and dihydroxylation as the key steps to access the basic premise of the 
skeleton and thence its elaboration to the targets is described in this chapter. 
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 The retrosynthetic analysis of our approach is shown in Scheme 12. 36 could be 
produced from 37 by using a reported procedure.
22b
 37 in turn could be obtained by 
desilylation/concomitant lactonisation of acyclic skeleton 38. Compound 38 in turn was 
prepared by the substrate controlled dihydroxylation of the cross-metathesis product 39. 
Olefin 39 could be realized from the cross-metathesis reaction of two olefinic fragments 40 
and 41. While, fragment 40 could be prepared from the known compound 42
26a 
by secondary 
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COOMe
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OH OH
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OH
36 37 38
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Scheme 12. Retrosynthetic analysis
 
 
alcohol protection, oxidation of primary alcohol and esterification of corresponding acid as 
the key steps, the other fragment 41 could be prepared by the TBDMS- etherification of the 
known phenyl vinyl carbinol (S) - 43 that was earlier prepared by us.
26b 
 
 
Results and discussion 
The synthesis of leiocarpin C commenced by accessing the two fragments 40 and 41 
independently.  
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Synthesis of fragment 40 
 Accordingly, first olefinic ester 40 was synthesized (Scheme 13). Thus, the secondary 
alcohol of the known diol 42 was protected as its silyl ether. In order to differentiate between 
the primary and secondary alcohols, a selective deprotection of the bis-TBDMS in the 
primary position was employed. Thus the bis-TBDMS ether 44 was formed (TBDMSCl, 
imidazole/CH2Cl2/0 
o
C/2 h) first followed by the selective removal (PTSA/MeOH/-10 
o
C/30 
min) of primary silyl group afforded 45 (74%). Primary alcohol 45 was oxidized to the 
corresponding aldehyde under Swern oxidation conditions (DMSO/(COCl)2/CH2Cl2/Et3N/-78 
o
C/1 h) which was further oxidized
27
 (NaClO2/NaH2PO4. 2H2O/2-methyl-2-butene/H2O/0 
o
C/3 h) to the acid 46 (86% over two steps). The resulting acid 46 was subsequently esterified 
to afford 40 (85%) using diazomethane in ether. 
 
Br
OH
OH OH OTBDMS
OTBDMS
b c
42 44
COOH
OTBDMS
46
OTBDMS
OH
45
a
d COOMe
OTBDMS
40
e
Reagents and conditions: (a) Ref 25a; (b) TBDMSCl, imidazole, CH2Cl2, 0
oC, 2 h, 95%; (c) PTSA, MeOH, -10 oC,
30 min, 74%; (d) i) DMSO, (COCl)2, Et3N, CH2Cl2,  -78 
oC, 1 h; ii) NaClO2, NaH2PO4, 2-methyl-2-butene, H2O, 0 
oC, 
3 h, 86%, (over two steps); (e) CH2N2, ether, 0
 oC, 5 min, 85%.
Scheme 13
 
 
Synthesis of fragment 17 
 The known phenyl vinyl carbinol 43 was protected (Scheme 14) as its silyl ether 41 
(TBDMSCl/imidazole/CH2Cl2/rt/80%). Based on our earlier results protection
26b
 was 
warranted for a facile cross-metathesis reaction. 
 
Ph
OTBDMS
Ph
OH
O H
a b
43 41
Reagents and conditions: (a) Ref 25b;  (b) TBDMSCl, imidazole, CH2Cl2, 
0 oC, 30 min., 80%.
Scheme 14
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 As outlined in Scheme 15, the crucial olefin cross-metathesis reaction
15,28
 using 
Grubbs’-II (IA, 10 mol%/CH2Cl2/rt/24 h) between olefinic ester 40 and 41 (1:1.5 ratio) 
resulted in the cross product 39 (60%) as a single stereo isomer and homo-dimer 47 (5%) of 
ester olefin 40. Homodimer 47 was effectively converted to the desired olefin 39 (60%) by 
using a second cross-metathesis reaction under the same conditions. Subsequently, the cross 
product 39 was dihydroxylated
29
 (OsO4/NMO/acetone/H2O in ratio of 4:1/rt) to produce the 
desired diol 38 as the required major isomer (75%), in a ratio of 80:20 which was separated 
by column chromatography (minor diastereomer 48 yield is 18%). Diol 38 was treated with 
amberlyst 15 resin in CH3CN to furnish the 37 (93%). The physical and spectroscopic data of 
37 were identical to the reported natural leiocarpin C [α]
25
D  -63.1 (c 0.30, CHCl3).
21, 22
 
Compound 37 was converted to (+)-goniodiol (36) by the known procedure. Similarly, the 
spectral data of 36 matched with that of the reported values.
22
 
 
OH
TBDMSO
COOMe
OTBDMSOH
Ph
OH
Ph
OH
c
OTBDMS
COOMe
OTBDMS
Ph
a
O
O
OH
OH
Ph
OH O
O
d
41
39
38 37 36
40
COOMe
OTBDMS
OTBDMS
COOMe
e
47
Reagents and conditions: (a) Grubbs-II (IA, 10 mol%), CH2Cl2, rt, 24 h, 60%;  (b) OsO4, NMO, acetone:H2O 
(4:1), rt, 24 h, 75%; (c) Amberlyst 15, CH3CN, rt, 2 h, 93%; (d) 21 b; (e) Grubbs-II (IA, 10 mol%), 41,
CH2Cl2, rt, 24 h, 60%.
b
Scheme 15
OH
TBDMSO
COOMe
OTBDMSOH
Ph
48
 
 
 In summary, the stereoselective synthesis of leiocarpin C was achieved by cross-
metathesis/dihydroxylation strategy to access the advanced intermediate (38) that was 
endowed with all stereogenic centers and functionalities and was easily elaborated to the 
target compound 37 in total 10 steps and in 24.5% overall yield. Alongside synthesis of (+)-
goniodiol 36 was also accomplished. 
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